← Back to Search

Cocoa extract + multivitamin for Cardiovascular Disease (COSMOS Trial)

Phase 4
Waitlist Available
Led By JoAnn E. Manson, MD
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

COSMOS Trial Summary

This trial will test whether taking cocoa extract and/or a multivitamin daily reduces the risk of developing cardiovascular disease or cancer.

Eligible Conditions
  • Cardiovascular Disease
  • Cancer

COSMOS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cardiovascular disease (CVD) events
Invasive cancer
Secondary outcome measures
Blood flavonoid levels
Breast cancer
Cardiovascular mortality
+11 more
Other outcome measures
Body composition
Bone mass density in hip, spine, and total body, and body composition
Physical performance
+2 more

COSMOS Trial Design

4Treatment groups
Active Control
Placebo Group
Group I: Cocoa extract + multivitamin placeboActive Control2 Interventions
Group II: Cocoa extract placebo + multivitaminActive Control2 Interventions
Group III: Cocoa extract + multivitaminActive Control2 Interventions
Group IV: Cocoa extract placebo + multivitamin placeboPlacebo Group2 Interventions

Find a Location

Who is running the clinical trial?

Mars, Inc.Industry Sponsor
19 Previous Clinical Trials
5,082 Total Patients Enrolled
Brigham and Women's HospitalLead Sponsor
1,609 Previous Clinical Trials
11,448,885 Total Patients Enrolled
PfizerIndustry Sponsor
4,567 Previous Clinical Trials
10,890,432 Total Patients Enrolled

Media Library

Cocoa extract Clinical Trial Eligibility Overview. Trial Name: NCT02422745 — Phase 4
Cardiovascular Disease Research Study Groups: Cocoa extract placebo + multivitamin placebo, Cocoa extract + multivitamin placebo, Cocoa extract placebo + multivitamin, Cocoa extract + multivitamin
Cardiovascular Disease Clinical Trial 2023: Cocoa extract Highlights & Side Effects. Trial Name: NCT02422745 — Phase 4
Cocoa extract 2023 Treatment Timeline for Medical Study. Trial Name: NCT02422745 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the FDA allow patients to take Cocoa extract + multivitamin?

"The safety of Cocoa extract + multivitamin is rated as a 3 by our team. This is due to the fact that this is a Phase 4 trial, which means that this treatment has been approved."

Answered by AI
Recent research and studies
~2181 spots leftby Apr 2025